Evidence map›Paper›PMID 19046328›Full record

ArticleJournal of neurochemistry2009

Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking.

Yingmiao Liu, Qi-An Sun, Qiang Chen, Tong H Lee, Yangzhong Huang, William C Wetsel, Gregory A Michelotti, Bruce A Sullenger, Xiuwu Zhang

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Therapeutic Potential of Aptamer-Protein Interactions.ACS pharmacology & translational science · 2022
    Review
  3. Article
  4. Aptamers as Valuable Molecular Tools in Neurosciences.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yingmiao LiuDepartment of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Qi-An Sun
Qiang Chen
Tong H Lee
Yangzhong Huang
William C Wetsel
Gregory A Michelotti
Bruce A Sullenger
Xiuwu Zhang
Duke University Hospital · USDuke Medical Center · USDuke University · US

Funding

TRANSPORT AND DELIVERY OF ANTISNESE OLIGONUCLEOTIDESP01GM059299 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, RUDOLPH · 2000 to 2010
$11.7M
COCAINE WITHDRAWAL: A WINDOW OF TREATMENT OPPORTUNITYR01DA012768 · NIDA · DUKE UNIVERSITY · PI LEE, TONG H · 1999 to 2009
$2.8M
Conditional Interference-mediated Reversal Cocaine ReinforcementR21DA021185 · NIDA · DUKE UNIVERSITY · PI ZHANG, XIUWU · 2006 to 2007
$422k
NIDA NIH HHS DA021185NIDA NIH HHS R01 DA012768NIDA NIH HHS R21 DA021185NIGMS NIH HHS GM059299NIGMS NIH HHS P01 GM059299
6 · The paper itself

Abstract

Phosphorylation at glutamate receptor subunit 1(GluR1) Ser845 residue has been widely accepted to involve in GluR1-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking, but the in vivo evidence has not yet been established. One of the main obstacles is the lack of effective methodologies to selectively target phosphorylation at single amino acid residue. In this study, the Escherichia coli-expressed glutathione-S-transferase-tagged intracellular carboxyl-terminal domain of GluR1 (cGluR1) was phosphorylated by protein kinase A for in vitro selection. We have successfully selected aptamers which effectively bind to phospho-Ser845 cGluR1 protein, but without binding to phospho-Ser831 cGluR1 protein. Moreover, pre-binding of the unphospho-cGluR1 protein with these aptamers inhibits protein kinase A-mediated phosphorylation at Ser845 residue. In contrast, the pre-binding of aptamer A2 has no effect on protein kinase C-mediated phosphorylation at Ser831 residue. Importantly, the representative aptamer A2 can effectively bind the mammalian GluR1 that inhibited GluR1/GluR1-containing AMPA receptor trafficking to the cell surface and abrogated forskolin-stimulated phosphorylation at GluR1 Ser845 in both green fluorescent protein-GluR1-transfected human embryonic kidney cells and cultured rat cortical neurons. The strategy to use aptamer to modify single-residue phosphorylation is expected to facilitate evaluation of the potential role of AMPA receptors in various forms of synaptic plasticity including that underlying psychostimulant abuse.

Indexed as

Amino Acid SequenceAnimalsAptamers, NucleotideBiotinylationCells, CulturedCerebral CortexCyclic AMP-Dependent Protein KinasesDose-Response Relationship, DrugEmbryo, MammalianGreen Fluorescent ProteinsHumansNeuronsPhosphorylationProtein BindingProtein Kinase CProtein TransportAptamers, NucleotideCyclic AMP-Dependent Protein KinasesGreen Fluorescent ProteinsProtein Kinase CReceptors, AMPASerine

Identifiers

PMID19046328
PMCPMC3636573
OpenAlexW2094383278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.